LivaNova (LIVN) Financials: Revenue & Earnings
LIVN$81.99+1.33 +1.65%
$4.50B
Market Cap
23.45
P/E
18.82
Forward P/E
—
Score
LivaNova (LIVN) Financials: Revenue & Earnings
LIVN price $81.99 +1.33 +1.65%
- Ticker
- LIVN
- Price
- $81.99
- Change
- +1.33 +1.65%
- Market cap ?
- $4.50B
- P/E ?
- 23.45
- Forward P/E ?
- 18.82
- Dividend yield ?
- 0.00%
- Beta ?
- 0.88
- Sector
- Healthcare
- Industry
- Medical - Devices
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1213900000 | 1012300000 | 1107000000 | 1084170000 | 934241000 | 1035365000 | 1021805000 | 1153545000 | 1253437000 | 1388100000 |
LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an…
Earnings and financials
LivaNova PLC (LIVN) trades at $81.99, with a market cap of $4.50B and a trailing P/E of 23.45. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1213900000 | 1012300000 | 1107000000 | 1084170000 | 934241000 | 1035365000 | 1021805000 | 1153545000 | 1253437000 | 1388100000 |
Insights · Dividends · Forecast · Financials · Learn